What the results of Wegovy’s longest clinical trial yet show about ...
2024年5月13日 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
Today, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in adults...
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ for ...
2023年8月25日 · The study of 529 patients, funded by drugmaker Novo Nordisk, found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a...
FDA approves Wegovy to reduce heart attack and stroke risk - NBC News
2024年3月8日 · The blockbuster weight loss drug Wegovy is now approved by the FDA to reduce heart disease risk, drugmaker Novo Nordisk said Friday.
FDA Approves New Drug Treatment for Chronic Weight …
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Wegovy approved to lessen heart attack, stroke risk in overweight ...
2024年3月8日 · The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA...
Why weight-loss drug Wegovy shows promise for heart disease - NBC News
2023年11月11日 · The weight-loss drug Wegovy can reduce the risk of heart attacks and strokes by 20% in adults with heart disease and obesity, according to new research.
Wegovy shown to reduce risk of heart attack, stroke in major ...
2023年8月8日 · CNN — The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart-related death by 20% in what’s being called a landmark clinical trial in people with cardiovascular...
Wegovy shown to cut risk of stroke and heart attacks ... - NBC News
2023年8月8日 · The popular obesity drug Wegovy cuts the risk of cardiovascular events, such as heart attack and stroke, by 20%, drugmaker Novo Nordisk said Tuesday. The findings are the first to demonstrate...
Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says
2023年8月8日 · A new obesity drug, Wegovy, slashed the risk of serious heart problems by 20 percent in a large trial, the drug’s maker said on Tuesday, a finding that could challenge the perception of weight...